RxDoctor Payments Data

John Denesopolis Iii, MD

Vascular Surgery · Bronx, NYNPI 1518320092

Payments from drug & device makers

$3,208in general payments, 2019–2025

Across 52 payments — averaging $61.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Medical LLC$859
  • Cardiovascular Systems Inc.$495
  • Medtronic$322
  • Polynovo North America LLC$288
  • Smith+Nephew$221
  • Lemaitre Vascular, Inc.$170
  • plus $854 from 11 others

What the payments were for

  • Food & beverage$3,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,208 in reported general payments places this provider in the 40th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York

Medicare billing

Part B allowed, 2024
$3,305,886
Medicare patients
164
Services billed
15,376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban29$22,303
ClopidogrelClopidogrel Bisulfate38$219

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →